[1]
N. Bendsöe, “A Non-interventional Study on Vismodegib for Basal Cell Carcinoma With A Treat-To-Target Regimen In Swedish Patients”, Dermatol Pract Concept, vol. 13, no. 2, p. e2023211, Apr. 2023, doi: 10.5826/dpc.1302a211.